Professor dr. Fred van Eenennaam is an expert on corporate governance & strategy. He is also well known for his expertise in the life sciences and healthcare industry. His consulting, executive education and research activities are focused on helping supervisory and executive boards take better decisions. Better decisions in terms of creating superior value, as an effective group process and in relation with actual implementation and day-to-day strategic leadership.

He has a family business background and after working for the strategic services unit of Accenture in the early 90’s, founded The Decision Group in 1995. He has written 12 books and more than 80 articles. His Harvard type cases on corporate governance and board room dynamics at Ahold, ABNAMRO, family and high-tech business and his lectures on strategy and decision-making under uncertainty are well received (4.2 score on 5 point scale 2007-2010).

Fred set up and chaired the Nyenrode Business Universiteit’s powerhouse on corporate governance from 2002 until 2010. He pioneered and created the leading and successful high- end executive programs:

• NCD Nyenrode Commissarissencyclus aimed at Dutch supervisory board members

• New Board Program aimed at current and future board members of listed companies

• The Strategic Leadership Program aimed at CEOs to create a company and personal agenda to navigate the company to the next level.

The Decision Group and Fred are pioneers in developing successful real action learning and leadership programs internationally for companies dealing with strategic change programs.

Fred was the promoter for honorary doctorates of dr Morris Tabaksblat (2008) and Professor dr Michael Porter (2009). He is co-chairman of the Global Impact Council of the Microeconomics of Competitiveness Initiative under the leadership of Prof. Michael Porter at his Institute of Strategy and Microeconomics of Competitiveness at Harvard Business School, Boston, Mass. The Dutch Cut Flower Case was jointly developed and is taught across the world at more than 80 universities as one of the core cases of economic and cluster theory.

Within the life sciences & healthcare sector, Fred has more than 17 years of extensive strategy consulting experience working on complex strategic projects. His aim is to contribute to a more entrepreneurial, effective, internationally competitive and recognized Dutch life sciences cluster as well as a world class Dutch healthcare system.

Recently, together with world-renowned experts as well as consultants from The Decision Group he developed high level courses on the strategic leadership of life sciences companies and the strategic leadership of healthcare organizations. Courses given on these subjects had an average score of 4.1 (2010).

Fred and his consultants have conducted several studies including recent policy studies on the strategic options of health insurance companies (2007), innovation and prevention reform policies within the Dutch healthcare system (2008), reconfiguration of strategies for hospitals (2009/10), cluster studies and the LSH/Nyenrode outlook for the Dutch red Biotech Cluster 2010 and 2011.

He works closely together with colleagues at St Gallen University, Harvard Business School, George Washington University, North Carolina State University and the University of Maryland as well as other universities on corporate governance & strategy topics and the life sciences and healthcare sectors.

He has served on the boards of several private companies, runs a diversified investment portfolio, consults across multiple industries and teaches in Europe and the Americas in executive MBA and other executive programs. He founded and chaired the Nyenrode Strategy Center at Nyenrode Business Universiteit between 2001 and 2009 and was appointed Nyenrode Professor of Strategy & Dynamics of Strategy at Nyenrode in 2003.

Topics

    Creating effective boards: dealing with board room dynamics and uncertainty

    Creating strategic insight

    Value creation and new business models

    Strategies for life sciences companies

    Strategies for hospitals and healthcare organizations

    Strategic decision making under uncertainty

    Scenario analyses and business modeling

    Micro economics of competitiveness

Business, Innovation, Creativity, Healthcare, Leadership, Economy, Finance, Strategic Leadership